Dianthus Therapeutics | MGTA - Loan Capital


Dianthus Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Celltrion KRW 63.29B 4.01B Sep/2025
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Kangmei Pharma CNY 78.45M 5.8M Sep/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Moderna USD 610M 584M Dec/2025
Organigram Holdings CAD 62.52M 13.88M Dec/2025
Organon & Co USD 8.78B 117M Sep/2025
Ovoca Bio EUR 0 0 Jun/2021
Pharma Mar EUR 36.68M 1.07M Dec/2025
Qiagen NV USD 1.65B 15.23M Dec/2025
Revvity USD 2.63B 543K Dec/2025
Sartorius EUR 3.41B 682.5M Sep/2025
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Tectonic Therapeutic USD 43K 57K Dec/2025
Tilray USD 268.59M 3.82M Sep/2025
Viatris USD 12.48B 7M Dec/2025
Xeris Pharmaceuticals USD 220.33M 866K Dec/2025
Zealand Pharma A/S 383.14M 727K Dec/2025
Zz Pientze Pharmaceu CNY 186.56M 9.75M Sep/2025